Elli Papaemmanuil

32PUBLICATIONS
314CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesRegenerative medicine (incl. stem cells)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Sep 28, 2026
Germline homologous recombination deficiency influences TP53-mutant clonal hematopoiesis fitness during platinum and PARP inhibitor treatment.

|Jul 22, 2026
Prior therapy defines mutation profiles in childhood cancer at relapse.

|Jul 02, 2026
A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies.

|Nov 27, 2025
Enabling whole genome sequencing analysis from FFPE specimens in clinical oncology.

Dylan Domenico, Gunes Gundem, Max F Levine

|Aug 26, 2025
SF3B1-mutant models of RNA mis-splicing uncover UBA1 as a therapeutic target in myelodysplastic neoplasms.

Jonas Thier, Sophia Hofmann, Katharina M Kirchhof

|Jul 15, 2025
Germline genetic variation impacts clonal hematopoiesis landscape and progression to malignancy.

Jie Liu, Duc Tran, Liying Xue

Pageof 6

Frequent Collaborators

15 joint publications

Max Levine

11 joint publications

Elsa Bernard

8 joint publications

Gunes Gundem

7 joint publications

Juan Esteban Arango-Ossa